Suggestions

Du même auteur

Efficacy and safety of teclistamab in patients with relapsed/refractory multiple myeloma after BCMA-targeting therapies

Archive ouverte | Touzeau, Cyrille | CCSD

International audience. Abstract Teclistamab is a B-cell maturation antigen (BCMA)–directed bispecific antibody approved for the treatment of patients with triple-class exposed relapsed/refractory multiple myeloma (...

Role of Proteasome Inhibitors in Relapsed and/or Refractory Multiple Myeloma

Archive ouverte | Leleu, Xavier | CCSD

International audience

Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study

Archive ouverte | Moreau, Philippe | CCSD

International audience. Background Bortezomib, thalidomide, and dexamethasone (VTd) plus autologous stem-cell transplantation is standard treatment in Europe for transplant-eligible patients with newly diagnosed mul...

Chargement des enrichissements...